Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
---|---|---|---|---|---|---|---|---|
HRMY | HARMONY BIOSCIENCES HOLDINGS INC | United States | $1.95B | 59,620,731 | 62.67% | 37.33% | Net Selling | Net Selling |
BNTX | BIONTECH SE | Germany | $30.02B | 240,993,998 | 16.46% | 0.00% | ||
DVAX | DYNAVAX TECHNOLOGIES CORP | United States | $1.25B | 127,686,631 | 69.09% | 30.91% | Net Selling | Net Selling |
CPRX | CATALYST PHARMACEUTICALS INC | United States | $1.75B | 105,654,395 | 79.61% | 17.05% | Net Selling | Net Buying |
OCUP | OCUPHIRE PHARMA INC | United States | $78.55M | 20,947,830 | 1.03% | 98.97% | Net Buying | |
KNSA | KINIKSA PHARMACEUTICALS LTD | Bermuda | $750.54M | 69,753,123 | 43.41% | 9.96% | Net Selling | Net Selling |
TBPH | THERAVANCE BIOPHARMA INC | Cayman Islands | $682.08M | 62,864,474 | 66.21% | 33.79% | Net Selling | Net Selling |
SELB | SELECTA BIOSCIENCES INC | United States | $213.11M | 153,318,915 | 34.92% | 38.28% | Net Buying | Net Selling |
VIR | VIR BIOTECHNOLOGY INC | United States | $3.11B | 133,531,379 | 61.03% | 38.97% | Net Selling | Net Selling |
UTHR | UNITED THERAPEUTICS CORP | United States | $10.37B | 46,301,656 | 87.61% | 12.39% | Net Selling | Net Selling |
CMRX | CHIMERIX INC | United States | $111.22M | 88,273,567 | 59.14% | 31.08% | Net Buying | Net Buying |
IMTX | IMMATICS NV | Germany | $529.03M | 76,670,699 | 44.41% | 0.00% | ||
CDMO | AVID BIOSERVICES INC | United States | $1.17B | 62,547,056 | 92.37% | 7.63% | Net Selling | Net Selling |
REGN | REGENERON PHARMACEUTICALS INC | United States | $89.83B | 109,325,532 | 69.99% | 30.01% | Net Selling | Net Selling |
MRNA | MODERNA INC | United States | $59.33B | 386,339,594 | 64.14% | 22.31% | Net Selling | Net Selling |
SIGA | SIGA TECHNOLOGIES INC | United States | $415.16M | 72,201,169 | 33.41% | 66.59% | Net Selling | |
ZYME | ZYMEWORKS INC | Canada | $578.93M | 64,041,287 | 60.52% | 39.48% | Net Buying | Net Buying |
MOLN | MOLECULAR PARTNERS AG | Switzerland | $217.64M | 36,044,706 | 2.55% | 0.00% | ||
VRTX | VERTEX PHARMACEUTICALS INC | United States | $81.00B | 257,091,441 | 91.64% | 1.52% | Net Selling | Net Selling |
GMAB | GENMAB A | Denmark | $24.91B | 65,961,573 | 69.29% | 0.00% | ||
MRVI | MARAVAI LIFESCIENCES HOLDINGS INC | United States | $3.51B | 250,879,331 | 33.93% | 66.07% | Net Selling | Net Selling |
ABCL | ABCELLERA BIOLOGICS INC | Canada | $2.17B | 287,686,199 | 44.27% | 45.83% | Net Buying | Net Buying |
VACC | VACCITECH PLC | United Kingdom | $85.88M | 38,338,764 | 26.68% | 55.14% | Net Selling | Net Selling |
GNFT | GENFIT SA | France | $204.24M | 49,815,489 | 4.33% | 0.00% | ||
NBIX | NEUROCRINE BIOSCIENCES INC | United States | $9.78B | 96,587,911 | 69.08% | 30.92% | Net Selling | Net Selling |
CGEM | CULLINAN ONCOLOGY INC | United States | $402.32M | 39,327,298 | 49.04% | 50.96% | Net Buying | Net Selling |
APVO | APTEVO THERAPEUTICS INC | United States | $14.73M | 7,239,471 | 13.31% | 50.90% | ||
RPTX | REPARE THERAPEUTICS INC | Canada | $414.05M | 42,077,896 | 59.26% | 40.74% | Net Selling | |
ITOS | ITEOS THERAPEUTICS INC | United States | $486.15M | 35,720,401 | 61.88% | 38.12% | Net Selling | Net Buying |
ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | United States | $636.53M | 26,555,483 | 85.25% | 14.62% | Net Buying | Net Selling |
VCYT | VERACYTE INC | United States | $1.61B | 72,149,636 | 64.34% | 35.66% | Net Selling | Net Selling |
ACET | ADICET BIO INC | United States | $247.42M | 42,954,975 | 73.19% | 26.81% | Net Selling | Net Selling |
XENE | XENON PHARMACEUTICALS INC | Canada | $2.26B | 63,037,991 | 95.84% | 4.03% | Net Selling | Net Buying |
ICPT | INTERCEPT PHARMACEUTICALS INC | United States | $559.63M | 41,670,120 | 49.86% | 50.14% | Net Selling | Net Selling |
PULM | PULMATRIX INC | United States | $10.66M | 3,652,285 | 7.87% | 92.13% | ||
PGEN | PRECIGEN INC | United States | $267.33M | 252,194,713 | 16.76% | 70.39% | Net Buying | Net Buying |
MORF | MORPHIC HOLDING INC | United States | $1.49B | 39,534,138 | 57.76% | 42.24% | Net Buying | Net Buying |
ZLAB | ZAI LAB LTD | China | $3.26B | 979,087,430 | 5.94% | 1.96% | Net Buying | Net Buying |
IDYA | IDEAYA BIOSCIENCES INC | United States | $664.36M | 48,387,222 | 86.10% | 13.90% | ||
VBLT | VASCULAR BIOGENICS LTD | Israel | $11.72M | 69,750,117 | 3.54% | 8.74% | ||
DBVT | DBV TECHNOLOGIES SA | France | $317.81M | 94,025,441 | 57.15% | 15.63% | ||
PPBT | PURPLE BIOTECH LTD | Israel | $33.08M | 184,815,092 | 0.09% | 0.00% | ||
ONTX | ONCONOVA THERAPEUTICS INC | United States | $15.33M | 20,969,559 | 7.40% | 83.87% | Net Selling | Net Selling |
IMRN | IMMURON LTD | Australia | $10.68M | 227,798,346 | 0.04% | 0.00% | ||
CRNX | CRINETICS PHARMACEUTICALS INC | United States | $865.78M | 53,908,865 | 81.66% | 18.34% | Net Selling | Net Selling |
XBIO | XENETIC BIOSCIENCES INC | United States | $6.16M | 15,166,596 | 4.58% | 26.79% | ||
BLU | BELLUS HEALTH INC | Canada | $911.28M | 126,567,121 | 89.84% | 0.00% | ||
LMNL | LIMINAL BIOSCIENCES INC | Canada | $117.96M | 31,042,560 | 0.59% | 0.00% | ||
TECH | BIO-TECHNE CORP | United States | $11.67B | 157,275,200 | 95.21% | 2.11% | Net Buying | Net Buying |
OMER | OMEROS CORP | United States | $292.15M | 62,828,765 | 31.04% | 5.93% | ||
SRRK | SCHOLAR ROCK HOLDING CORP | United States | $415.88M | 51,985,072 | 57.25% | 42.75% | Net Buying | Net Buying |
ALEC | ALECTOR INC | United States | $513.94M | 83,027,910 | 53.96% | 46.04% | Net Selling | Net Selling |
PTE | POLARITYTE INC | United States | $3.69M | 7,323,755 | 2.16% | 97.84% | Net Selling | Net Buying |
ALT | ALTIMMUNE INC | United States | $207.96M | 49,278,861 | 42.67% | 57.33% | Net Selling | Net Buying |
INCY | INCYTE CORP | United States | $16.11B | 222,965,018 | 78.83% | 21.17% | Net Selling | Net Buying |
BMRN | BIOMARIN PHARMACEUTICAL INC | United States | $18.14B | 186,528,784 | 97.63% | 1.50% | Net Selling | Net Selling |
SURF | SURFACE ONCOLOGY INC | United States | $42.44M | 60,716,873 | 29.65% | 70.35% | Net Selling | |
SLGL | SOL-GEL TECHNOLOGIES LTD | Israel | $89.74M | 23,129,469 | 24.64% | 0.00% | ||
ATXS | ASTRIA THERAPEUTICS INC | United States | $372.22M | 27,986,718 | 62.26% | 37.74% | Net Buying | |
ATRA | ATARA BIOTHERAPEUTICS INC | United States | $278.19M | 95,926,711 | 92.97% | 7.03% | Net Selling | Net Selling |
CWBR | COHBAR INC | United States | $5.20M | 2,906,926 | 0.94% | 99.06% | Net Buying | |
SILO | SILO PHARMA INC | United States | $6.63M | 3,158,797 | 0.68% | 5.03% | Net Buying | |
ARTL | ARTELO BIOSCIENCES INC | United States | $6.63M | 2,855,688 | 4.10% | 29.20% | Net Buying | |
CORT | CORCEPT THERAPEUTICS INC | United States | $2.34B | 107,899,316 | 30.30% | 69.70% | Net Buying | Net Buying |
CMMB | CHEMOMAB THERAPEUTICS LTD | Israel | $17.57M | 220,996,240 | 1.50% | 7.66% | Net Selling | Net Selling |
VYNE | VYNE THERAPEUTICS INC | United States | $10.05M | 3,264,272 | 22.22% | 77.78% | Net Buying | Net Buying |
NVIV | INVIVO THERAPEUTICS HOLDINGS CORP | United States | $3.03M | 2,860,446 | 0.95% | 99.05% | ||
DOMH | DOMINARI HOLDINGS INC | United States | $15.59M | 4,840,597 | 12.87% | 78.69% | Net Buying | |
INVA | INNOVIVA INC | United States | $766.42M | 68,126,089 | 63.59% | 36.41% | Net Selling | Net Buying |
VNDA | VANDA PHARMACEUTICALS INC | United States | $385.57M | 56,785,264 | 58.91% | 41.09% | Net Selling | Net Selling |
BEAM | BEAM THERAPEUTICS INC | United States | $2.22B | 72,397,631 | 76.70% | 23.30% | Net Selling | Net Selling |
TRVI | TREVI THERAPEUTICS INC | United States | $111.08M | 60,045,096 | 19.11% | 80.89% | Net Buying | Net Buying |
MEIP | MEI PHARMA INC | United States | $30.52M | 133,260,865 | 37.14% | 9.31% | Net Buying | Net Buying |
LSTA | LISATA THERAPEUTICS INC | United States | $25.95M | 7,998,342 | 0.83% | 99.17% | Net Buying | Net Selling |
PSTX | POSEIDA THERAPEUTICS INC | United States | $266.50M | 86,527,203 | 49.73% | 43.92% | Net Buying | Net Selling |
IMMP | IMMUTEP LTD | Australia | $147.72M | 879,295,626 | 0.47% | 0.00% | ||
ADMA | ADMA BIOLOGICS INC | United States | $735.34M | 222,155,625 | 68.71% | 26.48% | Net Selling | Net Selling |
SPRO | SPERO THERAPEUTICS INC | United States | $76.23M | 52,571,813 | 27.05% | 61.72% | Net Selling | Net Selling |
FBRX | FORTE BIOSCIENCES INC | United States | $21.22M | 21,007,069 | 18.10% | 33.47% | Net Buying | |
ACRS | ACLARIS THERAPEUTICS INC | United States | $539.55M | 66,692,964 | 65.46% | 34.54% | Net Selling | Net Selling |
PRTA | PROTHENA CORP PUBLIC LTD CO | Ireland | $2.55B | 52,564,434 | 51.02% | 48.98% | Net Buying | Net Buying |
ACST | ACASTI PHARMA INC | Canada | $20.52M | 44,612,831 | 0.11% | 20.34% | ||
PRTC | PURETECH HEALTH PLC | United States | $834.32M | 287,796,585 | 0.48% | 0.00% | ||
ABIO | ARCA BIOPHARMA INC | United States | $28.68M | 14,410,143 | 1.80% | 98.20% | Net Buying | |
EPIX | ESSA PHARMA INC | Canada | $130.95M | 44,092,374 | 72.45% | 27.55% | Net Buying | |
JNCE | JOUNCE THERAPEUTICS INC | United States | $96.46M | 52,140,277 | 59.53% | 40.47% | Net Buying | Net Buying |
FIXX | HOMOLOGY MEDICINES INC | United States | $59.41M | 57,678,435 | 36.59% | 20.22% | Net Selling | Net Selling |
AUTL | AUTOLUS THERAPEUTICS PLC | United Kingdom | $318.46M | 173,074,510 | 62.34% | 0.00% | ||
CGEN | COMPUGEN LTD | Israel | $60.81M | 86,624,643 | 18.70% | 0.00% | ||
SAGE | SAGE THERAPEUTICS INC | United States | $2.51B | 59,717,608 | 69.94% | 30.06% | Net Buying | Net Buying |
IKNA | IKENA ONCOLOGY INC | United States | $125.09M | 36,257,493 | 72.44% | 23.38% | Net Buying | |
RNA | AVIDITY BIOSCIENCES INC | United States | $1.09B | 70,807,973 | 81.46% | 18.54% | Net Buying | Net Buying |
AEZS | AETERNA ZENTARIS INC | Canada | $12.72M | 4,855,876 | 0.72% | 0.00% | ||
CRDF | CARDIFF ONCOLOGY INC | United States | $73.72M | 44,677,169 | 17.24% | 34.48% | Net Buying | |
UPC | UNIVERSE PHARMACEUTICALS INC | China | $12.66M | 21,750,000 | 0.30% | 0.00% | ||
AADI | AADI BIOSCIENCE INC | United States | $176.92M | 24,436,990 | 30.68% | 69.32% | Net Buying | |
AFMD | AFFIMED NV | Germany | $111.41M | 149,339,335 | 54.11% | 0.00% | ||
EXEL | EXELIXIS INC | United States | $6.29B | 324,087,337 | 86.44% | 2.82% | Net Selling | Net Selling |
BCYC | BICYCLE THERAPEUTICS PLC | United Kingdom | $638.55M | 30,021,071 | 54.96% | 45.04% | Net Selling | Net Selling |
LUMO | LUMOS PHARMA INC | United States | $27.21M | 8,219,292 | 17.99% | 82.01% | Net Buying | Net Buying |